Demystifying medication safety: Making sense of the terminology

Research in Social and Administrative Pharmacy

Volumn 2, Issue 2, 2006, Pages 280-289

  Ackroyd Stolarz, Stacy ^a   Hartnell, Nicole ^a   MacKinnon, Neil J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adverse drug events; Adverse drug reactions; Drug related morbidity; Drug related problems; Drug therapy problems; Medication errors; Medication misadventures; Medication safety

Indexed keywords

DRUG;

ARTICLE; DRUG SURVEILLANCE PROGRAM; MEDICATION ERROR; NOMENCLATURE; SAFETY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; SAFETY; TERMINOLOGY; TERMINOLOGY AS TOPIC;

EID: 33745137874     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2006.01.001     Document Type: Article

References (26)

1. In: Kohn L.T., Corrigan J.M., and Donaldson M.S. (Eds). To Err is Human. Building a Safer Health System (1999), National Academy Press, Washington, DC
2. Ernst F.R., and Grizzle A.J. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 41 (2001) 192-199
3. Nebeker J.R., Barach P., and Samore M.H. Clarifying adverse drug events: a clinician's guide to terminology, documentation and reporting. Ann Intern Med 140 (2004) 795-801
4. Yu K.H., Nation R.L., and Dooley M.J. Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough?. Qual Saf Health Care 14 (2005) 358-363
5. Otero M.J., and Schmitt E. Clarifying terminology for adverse drug events. Ann Intern Med 142 (2005) 77
6. Christoffel T., and Scavo Gallagher S. Injury Prevention and Public Health: Practical Knowledge, Skills and Strategies (1999), Aspen Publishers, Gaithersburg, Md
7. Hepler C.D. Understanding adverse drug therapy outcomes. In: Hepler C.D., and Segal R. (Eds). Preventing Medication Errors and Improving Drug Therapy Outcomes (2003), CRC Press, Boca Raton, Fla
8. Hepler C.D., and Strand L.M. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47 (1990) 533-543
9. Strand L.M., Morley P.C., Cipolle R.J., Ramsey R., and Lamsam G.D. Drug-related problems: their structure and function. Drug Intell Clin Pharm 24 (1990) 1093-1097
10. Hepler C.D., and Grainger-Rousseau T.J. Pharmaceutical care versus traditional treatment: is there a difference?. Drugs 49 (1995) 1-10
11. Manasse Jr. H.R. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 46 (1989) 929-944
12. Manasse Jr. H.R. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm 46 (1989) 1141-1152
13. American Society of Health-System Pharmacists (ASHP). Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health Syst Pharm 55 (1998) 165-166
14. Bates D.W., Boyle D.L., Vander Vliet M.B., Schneider J., and Leape L.L. Relationship between medication errors and adverse drug events. J Gen Intern Med 10 (1995) 199-205
15. Bates D.W., Cullen D.J., Laird N., et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA 274 (1995) 29-34
16. Brennan T.A., Leape L.L., Laird N.M., et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med 324 (1991) 370-376
17. Zellmer W.A. Medication error versus medication misadventure-what's in a name?. Am J Hosp Pharm 50 (1993) 315-318
18. Edwards I.R., and Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 356 (2000) 1255-1259
19. World Health Organization. International drug monitoring: the role of national centres. Technical Report Series No. 498. World Health Organization, Geneva, Switzerland, 1972.
20. Canadian Adverse Drug Reaction Monitoring Program (CADRMP). Available from:. Accessed 12.07.05
21. Canadian Medication Incident Reporting and Prevention System (CMIRPS). Available from:. Accessed 12.07.05
22. Sutcliffe K.M. Defining and classifying medical error: lessons for learning. Qual Saf Health Care 13 (2004) 8-9
23. Schneitman-McIntire O., Farnen T.A., Gordon N., Chan J., and Toy W.A. Medication misadventures resulting in emergency department visits at an HMO medical centre. Am J Health Syst Pharm 53 (1996) 1416-1422
24. Easton-Carter K.L., Chapman C.B., and Brian J.E. Issues in the interpretation and design of studies investigating drug-related morbidity and mortality. J Pharm Pract Res (2002) 235-239
25. Michel P., Quenon J.L., de Sarasqueta A.M., and Scemama O. Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. BMJ 328 (2004) 199
26. Tamuz M., Thomas E.J., and Franchois K.E. Qual Saf Health Care 13 (2004) 13-20